Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Infectious Disease · Typhoid Fever

Prevention, Survivorship, and the Chronic Carrier State

At a Glance

After recovering from typhoid fever, 2% to 5% of people become chronic carriers who feel healthy but continue to spread the bacteria. The bacteria often hide in the gallbladder. Vaccination and strict hygiene are critical to preventing the ongoing spread of typhoid in communities.

Recovery from typhoid fever is a significant milestone, but the journey does not always end when the fever breaks. Preventing future infections and understanding the risk of becoming a “carrier” are essential for long-term health and community safety [1][2].

The Chronic Carrier State

In about 2% to 5% of people who get typhoid, the bacteria are not completely cleared from the body after they recover [3]. These individuals become chronic carriers [4].

  • The Gallbladder Connection: The bacteria often “hide” in the gallbladder [5]. If a person has gallstones, S. Typhi can form a biofilm—a tough, slimy coating—on the surface of the stones [6][7]. This biofilm acts like a shield, protecting the bacteria from both your immune system and antibiotics [6][8].
  • Silent Spreaders: Carriers feel completely healthy and have no symptoms, but they continue to shed live bacteria in their stool for more than a year [3][9]. This is how typhoid persists in communities and why food safety is so critical [10].
  • Management & Risks: Carriers are often treated with a long-term course of high-dose antibiotics [5]. If antibiotics fail and gallstones are present, doctors may recommend a cholecystectomy (surgical removal of the gallbladder) to eliminate the bacterial reservoir [5][11]. Additionally, persistent gallbladder inflammation from chronic carriage has been linked to an increased risk of gallbladder cancer later in life, making long-term medical monitoring essential [12][7].

Preventing Spread at Home

Because the bacteria are shed in stool and urine, preventing the spread of typhoid in your own home during recovery is incredibly important [13].

  • Home Isolation: Try to use a separate bathroom from the rest of your household if possible.
  • Strict Bathroom Hygiene: Wash your hands thoroughly with soap and water after every bathroom trip. Clean bathroom surfaces regularly.
  • Avoid Food Prep: Do not prepare food for others while you are actively recovering or shedding the bacteria [14].

Prevention through Vaccination

Vaccination is one of the most powerful tools available to stop the spread of typhoid. There are three main types of vaccines [15]:

  1. Typhoid Conjugate Vaccine (TCV): This is the newest and most effective vaccine [15]. It provides strong, long-lasting protection (at least 2–4 years) and is the only vaccine that can be given to infants as young as 6 months [16][17].
  2. Vi Polysaccharide (ViPS): An injectable vaccine for people aged 2 and older. It requires a booster every 2 to 3 years and is less effective in young children [15][18].
  3. Ty21a: An oral vaccine (pills) for those aged 6 and older. It involves taking several doses over a week and requires a booster every 5 years [15][19]. Note: This is a live-attenuated vaccine, meaning it should not be given to pregnant women or individuals with weakened immune systems [15].

Safe Habits (WASH Strategies)

Even if you are vaccinated, practicing good WASH (Water, Sanitation, and Hygiene) habits is vital, especially when traveling or living in areas where typhoid is common [20][21].

  • Water Safety: Only drink water that has been bottled and sealed, or water that has been boiled for at least one minute [1][22]. Avoid ice unless you know it was made from safe water.
  • Food Safety: “Boil it, cook it, peel it, or forget it.” Eat food that is served steaming hot [1]. Avoid raw vegetables and fruits that you haven’t peeled yourself.

Common questions in this guide

Can I spread typhoid after I recover from the infection?
Yes, about 2% to 5% of people become chronic carriers after recovering from typhoid. They feel completely healthy and have no symptoms, but they can continue to shed the live bacteria in their stool for over a year.
How do gallstones affect typhoid recovery?
Typhoid bacteria can hide in the gallbladder by forming a protective slimy coating, called a biofilm, on the surface of gallstones. This shield protects the bacteria from your immune system and antibiotics, making it much harder to clear the infection.
What treatments are available if I become a chronic typhoid carrier?
Chronic carriers are typically treated with a long-term course of high-dose antibiotics. If the antibiotics fail to clear the bacteria and gallstones are present, your doctor may recommend surgically removing the gallbladder.
Which typhoid vaccine is best for young children?
The Typhoid Conjugate Vaccine (TCV) is the newest and most effective option available. It provides strong, long-lasting protection and is the only typhoid vaccine that can be safely given to infants as young as 6 months.
How can I prevent spreading typhoid to my family while recovering?
You should use a separate bathroom if possible and wash your hands thoroughly with soap and water after every use. It is also extremely important that you do not prepare food for anyone else while you are actively recovering or shedding the bacteria.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I still shedding Salmonella Typhi bacteria, and what tests will be used to confirm I am no longer a carrier?
  2. 2.If I have gallstones, does that make it more likely that I will become a chronic carrier?
  3. 3.Is the Typhoid Conjugate Vaccine (TCV) the best option for my child, and when should they get their first dose?
  4. 4.If I am a carrier, what is the current success rate of long-term antibiotics versus a cholecystectomy for me?
  5. 5.When should I receive a booster dose of the typhoid vaccine if I am traveling back to an endemic area?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Emergence of Multi-Resistant Enteric Infection In A Paediatric Unit Of Karachi, Pakistan.

    Aziz S, Malik L

    JPMA. The Journal of the Pakistan Medical Association 2018; (68(12)):1848-1850.

    PMID: 30504956
  2. 2

    Complications and mortality of typhoid fever: A global systematic review and meta-analysis.

    Marchello CS, Birkhold M, Crump JA

    The Journal of infection 2020; (81(6)):902-910 doi:10.1016/j.jinf.2020.10.030.

    PMID: 33144193
  3. 3

    Extensively drug-resistant typhoid fever in Pakistan.

    Rasheed MK, Hasan SS, Babar ZU, Ahmed SI

    The Lancet. Infectious diseases 2019; (19(3)):242-243 doi:10.1016/S1473-3099(19)30051-9.

    PMID: 30833059
  4. 4

    A mouse model for studying chronic Salmonella Typhi infection and anti-biofilm interventions.

    Cole AL, Woolard KJ, Sorge A, et al.

    mBio 2026; (17(2)):e0347625 doi:10.1128/mbio.03476-25.

    PMID: 41410426
  5. 5

    Chronic Salmonella Typhi carriage at sites other than the gallbladder.

    Hoffman SA, Sikorski MJ, Levine MM

    PLoS neglected tropical diseases 2023; (17(3)):e0011168 doi:10.1371/journal.pntd.0011168.

    PMID: 36952437
  6. 6

    Salmonella Typhi Haplotype 58 biofilm formation and genetic variation in isolates from typhoid fever patients with gallstones in an endemic setting in Kenya.

    Muturi P, Wachira P, Wagacha M, et al.

    Frontiers in cellular and infection microbiology 2024; (14()):1468866 doi:10.3389/fcimb.2024.1468866.

    PMID: 39606745
  7. 7

    Biofilm Producing Salmonella Typhi: Chronic Colonization and Development of Gallbladder Cancer.

    Di Domenico EG, Cavallo I, Pontone M, et al.

    International journal of molecular sciences 2017; (18(9)) doi:10.3390/ijms18091887.

    PMID: 28858232
  8. 8

    Response of Salmonella Typhi to bile-generated oxidative stress: implication of quorum sensing and persister cell populations.

    Walawalkar YD, Vaidya Y, Nayak V

    Pathogens and disease 2016; (74(8)).

    PMID: 27609462
  9. 9

    Siblings with typhoid fever: An investigation of intrafamilial transmission, clonality, and antibiotic susceptibility.

    Meyer Sauteur PM, Stevens MJA, Paioni P, et al.

    Travel medicine and infectious disease 2020; (34()):101498 doi:10.1016/j.tmaid.2019.101498.

    PMID: 31580900
  10. 10

    High prevalence of typhoidal Salmonella enterica serovars excreting food handlers in Karachi-Pakistan: a probable factor for regional typhoid endemicity.

    Siddiqui TR, Bibi S, Mustufa MA, et al.

    Journal of health, population, and nutrition 2015; (33()):27 doi:10.1186/s41043-015-0037-6.

    PMID: 26825058
  11. 11

    Fecal Shedding, Antimicrobial Resistance and In Vitro Biofilm formation on Simulated Gallstones by Salmonella Typhi Isolated from Typhoid Cases and Asymptomatic Carriers in Nairobi, Kenya.

    Muturi P, Wachira P, Wagacha M, et al.

    International journal of clinical microbiology 2024; (1(2)):23-36 doi:10.14302/issn.2690-4721.ijcm-24-5030.

    PMID: 39319013
  12. 12

    Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis.

    Koshiol J, Wozniak A, Cook P, et al.

    Cancer medicine 2016; (5(11)):3310-3235 doi:10.1002/cam4.915.

    PMID: 27726295
  13. 13

    Domestic River Water Use and Risk of Typhoid Fever: Results From a Case-control Study in Blantyre, Malawi.

    Gauld JS, Olgemoeller F, Nkhata R, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (70(7)):1278-1284 doi:10.1093/cid/ciz405.

    PMID: 31144715
  14. 14

    Environmental Transmission of Typhoid Fever in an Urban Slum.

    Akullian A, Ng'eno E, Matheson AI, et al.

    PLoS neglected tropical diseases 2015; (9(12)):e0004212 doi:10.1371/journal.pntd.0004212.

    PMID: 26633656
  15. 15

    Prevention of enteric fever in travellers with typhoid conjugate vaccines.

    Britto C, Jin C, Theiss-Nyland K, Pollard AJ

    Journal of travel medicine 2018; (25(1)) doi:10.1093/jtm/tay120.

    PMID: 30476199
  16. 16

    Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.

    Shakya M, Voysey M, Theiss-Nyland K, et al.

    The Lancet. Global health 2021; (9(11)):e1561-e1568 doi:10.1016/S2214-109X(21)00346-6.

    PMID: 34678198
  17. 17

    Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial.

    Nampota-Nkomba N, Nyirenda OM, Khonde L, et al.

    The Lancet. Global health 2022; (10(9)):e1326-e1335 doi:10.1016/S2214-109X(22)00275-3.

    PMID: 35961356
  18. 18

    Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

    Rijpkema S, Hockley J, Logan A, et al.

    Biologicals : journal of the International Association of Biological Standardization 2018; (56()):29-38 doi:10.1016/j.biologicals.2018.09.001.

    PMID: 30201529
  19. 19

    Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.

    Batool R, Tahir Yousafzai M, Qureshi S, et al.

    Vaccine 2021; (39(40)):5858-5865 doi:10.1016/j.vaccine.2021.08.051.

    PMID: 34465474
  20. 20

    Incidence of Enteric Fever in a Pediatric Cohort in North India: Comparison with Estimates from 20 Years Earlier.

    Sinha B, Rongsen-Chandola T, Goyal N, et al.

    The Journal of infectious diseases 2021; (224(Supple 5)):S558-S567 doi:10.1093/infdis/jiab046.

    PMID: 35238363
  21. 21

    Un-Matched 1:1 Retrospective Case-Control Study of the Transmission of Typhoid Fever in Neno District, Malawi.

    Talabuku P, Mwalwanda A, Chavura E, et al.

    Public health challenges 2025; (4(4)):e70136 doi:10.1002/puh2.70136.

    PMID: 41080792
  22. 22

    Associations of water, sanitation, and hygiene with typhoid fever in case-control studies: a systematic review and meta-analysis.

    Kim C, Goucher GR, Tadesse BT, et al.

    BMC infectious diseases 2023; (23(1)):562 doi:10.1186/s12879-023-08452-0.

    PMID: 37644449

This page provides educational information on typhoid prevention and the chronic carrier state. Always consult your healthcare provider or an infectious disease specialist for personalized medical advice and testing.

Get notified when new evidence is published on Typhoid.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.